Global Oncology Drugs Industry Market Analysis & Competitive Research (2023 – 2030)

The most effective and innovative research report on "Global Oncology Drugs Market Research Report 2022-2030" gives the overall forecast and future prospects for the Oncology Drugs Market. The report highlights major market programs, including top market players, latest Deployment Mode trends, key technical growth and development opportunities in the global Oncology Drugs market, which helps for industry intelligence experts and investors make successful business decisions. In addition, the report is indicating on why interest is increasing for Oncology Drugs and all important factors that contribute to overall market growth. The Global Statistical Survey Report of Oncology Drugs is a described for the size of the market in the year 2023 and is expected to reach USD XX million from 2023 to 2030.
The Global Oncology Drugs Market Research Report 2022-2030 covers market growth drivers and challenges, key market regulations’ information, analysis of new Products from the market leaders and key market trends, market share analysis for major players, supply chain and distribution analysis, Product and Deployment Mode trends, pricing information, emerging applications, technologies and major recent market developments. This information has also been provided for the major country markets in these regions. Market size and growth potential is assessed for these major country markets. Market growth drivers, restraints, government regulations, market share analysis by major competitors, recent major market developments (Product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
The study gives a short review of the Worldwide Oncology Drugs in the present situation, and talks about the development of the Oncology Drugs and its worldwide effect. It comprehensively segments the Oncology Drugs by type, Deployment Mode and application. The Oncology Drugs type and application market is additionally bifurcated by geologies and Verticals. Regions secured incorporate North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and Latin America; while application secured incorporate Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, and Others.
Market by type incorporates analysis as Вlооd Саnсеr, Вrеаѕt Саnсеr, Gаѕtrоіntеѕtіnаl Саnсеr, Рrоѕtаtе Саnсеr, аnd Оthеrѕ.. The Вlооd Саnсеr section is projected to steer the Oncology Drugs market, in terms valuable, throughout the forecast amount.
This report additionally offers dominant part of the most recent and freshest industry information that covers the general market circumstance alongside future prospects for Oncology Drugs Market around the globe. The examination think about incorporates huge information and furthermore figures of the Worldwide market which makes the report accommodating asset for promoting individuals, experts, industry officials, deals and item supervisors, and other individuals who need significant industry information in a prepared to-get to arrange alongside clear introduction of diagrams, pictures and tables.
North America is calculable to carry the most important market share and expected to dominate the Global Oncology Drugs Market from 2023 to 2030. This region has the foremost dominance with property and well-established economies, empowering the region to powerfully invest in analysis and Development (R&D) activities, thereby contributory to the event of recent technologies in Oncology Drugs Market security and analytics. Further, the government’s support and significant investments by numerous well-established organizations square measure driving the expansion of the market within the North American region.
Market player analysis of major companies such as Rосhе, Nоvаrtіѕ, Сеlgеnе, Аmgеn, Јоhnѕоn & Јоhnѕоn, GlахоЅmіthКlіnе, Еlі lіllу & Со, Рfіzеr, Меrсk & Со., аnd Ѕаnоfі, and others.

Particular Scope
Region
  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • South America
Historic Year 2015 tо 2019
Estimated Year 2020
Forecast Year 2021 tо 2029

THE OBJECTIVES OF THIS STUDY

  • To define, describe, segment, and forecast the Market on the basis of Product Types, Grade Type, End Use Type, and across region.
  • To forecast revenue of the market segments with respect to main European countries
  • To identify the micro markets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market.
  • To strategically analyze market segments and sub segments with respect to individual growth trends, prospects, and contributions to the overall market.
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players and comprehensively analyze their market position and core competencies in terms of market developments and growth strategies.
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the European market.

1 INTRODUCTION
1.1 OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.3 RESEARCH METHODOLOGY
1.3.1 SECONDARY DATA
1.3.2 PRIMARY DATA
1.3.3 MARKET SIZE ESTIMATION
1.3.4 BOTTOM-UP APPROACH
1.3.5 TOP-DOWN APPROACH
1.4 MARKET ASSUMPTION
1.5 STAKEHOLDERS
1.6 CURRENCY
1.7 YEARS CONSIDERED
1.8 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.2.1 OPPORTUNITY 1
3.2.2 OPPORTUNITY 2
3.2.3 OPPORTUNITY 3
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 COVID-19 IMPACTS ON GLOBAL MARKET (DEMAND AND SUPPLY SIDE)
3.7 PORTER’S FIVE FORCES MODEL
3.7.1 DEGREE OF COMPETITION
3.7.2 BARGAINING POWER OF BUYERS
3.7.3 BARGAINING POWER OF SUPPLIERS
3.7.4 THREAT FROM SUBSTITUTES
3.7.5 THREAT FROM NEW ENTRANTS
4 ONCOLOGY DRUGS TYPE ANALYSIS
4.1 INTRODUCTION
4.2 HISTORICAL MARKET TYPE ANALYSIS, 2017-2021
4.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
4.4 Y-O-Y GROWTH TREND ANALYSIS
4.5 ВLООD САNСЕR
4.6 ВRЕАЅT САNСЕR
4.7 GАЅTRОІNTЕЅTІNАL САNСЕR
4.8 РRОЅTАTЕ САNСЕR
4.9 ОTHЕRЅ
5 ONCOLOGY DRUGS MARKET DISTRIBUTION CHANNEL ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET DISTRIBUTION CHANNEL ANALYSIS, 2017-2021
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 RETAIL PHARMACIES/DRUG STORES
5.6 HOSPITAL PHARMACIES
5.7 OTHERS
6 ONCOLOGY DRUGS MARKET ROUTE OF ADMINISTRATION ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET ROUTE OF ADMINISTRATION ANALYSIS, 2017-2021
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 ORAL
6.6 PARENTERAL
6.7 OTHERS
7 ONCOLOGY DRUGS MARKET DRUG CLASSIFICATION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET DRUG CLASSIFICATION ANALYSIS, 2017-2021
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 BRANDED
7.6 GENERIC
8 ONCOLOGY DRUGS MARKET APPLICATION ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2017-2021
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 СHЕMОTHЕRАРУ
8.6 ТАRGЕTЕD ТHЕRАРУ
8.7 ІMMUNОTHЕRАРУ (ВІОLОGІС ТHЕRАРУ)
8.8 НОRMОNАL ТHЕRАРУ
8.9 ОTHЕRЅ
9 GLOBAL ONCOLOGY DRUGS REGIONAL ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
9.2.3 Y-O-Y GROWTH TREND ANALYSIS
9.2.3.1 U.S.
9.2.3.2 Canada
9.2.3.3 Mexico
9.3 ASIA-PACIFIC
9.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.3.2 Y-O-Y GROWTH TREND ANALYSIS
9.3.2.1 China
9.3.2.2 Japan
9.3.2.3 Korea
9.3.2.4 India
9.3.2.5 Rest of Asia-Pacific
9.4 MIDDLE EAST AND AFRICA
9.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
9.4.3 Y-O-Y GROWTH TREND ANALYSIS
9.4.3.1 Saudi Arabia
9.4.3.2 UAE
9.4.3.3 Egypt
9.4.3.4 Nigeria
9.4.3.5 South Africa
9.5 EUROPE
9.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
9.5.3 Y-O-Y GROWTH TREND ANALYSIS
9.5.3.1 Germany
9.5.3.2 France
9.5.3.3 UK
9.5.3.4 Russia
9.5.3.5 Italy
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
9.6.3 Y-O-Y GROWTH TREND ANALYSIS
9.6.3.1 Brazil
9.6.3.2 Argentina
9.6.3.3 Columbia
9.6.3.4 Rest of South America
10 COUNTRY LEVEL ANALYSIS
10.1 UNITED STATES
10.2 CANADA
10.3 MEXICO
10.4 CHINA
10.5 JAPAN
10.6 INDIA
10.7 KOREA
10.8 SAUDI AREBIA
10.9 UAE
10.10 EGYPT
10.11 NIGERIA
10.12 SOUTH AFRICA
10.13 GERMANY
10.14 FRANCE
10.15 UK
10.16 RUSSIA
10.17 ITALY
10.18 BRAZIL
10.19 ARGENTINA
10.20 COLUMBIA
11 MARKET PLAYERS
11.1 RОСHЕ
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 REGIONAL REVENUE
11.1.4 RECENT DEVELOPMENTS
11.2 NОVАRTІЅ
11.3 СЕLGЕNЕ
11.4 АMGЕN
11.5 ЈОHNЅОN & ЈОHNЅОN
11.6 GLАХОЅMІTHКLІNЕ
11.7 ЕLІ LІLLУ & СО
11.8 РFІZЕR
11.9 МЕRСK & СО.
11.10 ЅАNОFІ
11.11 ABBVIE INC.
11.12 ADCOCK INGRAM
11.13 ADORX THERAPEUTICS
11.14 AID GENOMICS LIMITED
11.15 AMGEN
11.16 APIKOS PHARMA
11.17 AQVIDA GMBH
11.18 ARLAK BIOTECH
11.19 ASPEN
11.20 ASTELLAS PHARMA INC
11.21 ASTRAZENECA PLC
11.22 BAXTER INTERNATIONAL INC.
11.23 BAYER AG
11.24 BEIGENE
11.25 BIOPHARMA-MEA
11.26 CAMBRIDGE CANCER GENOMICS
11.27 CARSGEN THERAPEUTICS
11.28 CATALYST CLINICAL RESEARCH
11.29 CELENTYX
11.30 CELLOMATICS BIOSCIENCES
11.31 CELNOVA PHARMA
11.32 CHUGAI PHARMACEUTICAL CO.LTD
11.33 CLOVIS ONCOLOGY
11.34 CSTONE PHARMA
11.35 CURETECH LTD.
11.36 DAIICHI PHARMACEUTICAL AND SANKYO
11.37 EISAI CO., LTD.
11.38 EUROFARMA LABORATÓRIOS S.A.
11.39 EUROLAB
11.40 F. HOFFMANN-LA ROCHE AG
11.41 HEALTHKIND LABS PVT LTD
11.42 JULPHAR
11.43 JW THERAPEUTICS
11.44 KITOV PHARMA LIMITED
11.45 KOLAZ BIOTECH
11.46 KYOWA HAKKO KIRIN
11.47 MITSUBISHI TANABE PHARMA CORPORATION
11.48 NEOPHARMA
11.49 NEOTX
11.50 NOVO NORDISK A/S
11.51 OTSUKA PHARMACEUTICAL CO., LTD.
11.52 PHARMACYCLICS
11.53 PIERRE FABRE GROUP
11.54 SHIONOGI CO., LTD.
11.55 SWISSCHEM HEALTHCARE PVT.LTD.
11.56 TAKEDA PHARMACEUTICALS
11.57 TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.58 TUTEUR ARGENTINA
12 ABOUT US

Table and Figure

Request For Customization

Purchase Option

Single User
$ 4585
340436.25
Multi User
$ 7585
563186.25
Enterprise User
$ 9585
711686.25

Still Need More Information? :